Media alert: European Society of Cardiology Congress 2009

June 29, 2009

The latest news on procedures, drugs and equipment in the field of cardiology will be presented at the European Society of Cardiology congress which will take place in Barcelona, from 29 August to 2 September.

With over 30,000 participants, the ESC Congress is the world's biggest cardiology meeting.

A record number of abstract submissions - 9,848 - were registered this year, reflecting how the meeting is now the main platform for cardiovascular research. A growing number of abstracts came from outside Europe, reflecting the truly international dimension of the meeting.

"Because cardiovascular disease is the main cause of mortality and morbidity and in recognition of the major advances that have been made in this field we felt that prevention and risk factor identification represented a really important theme to highlight" explains Prof Fausto Pinto, chairperson of the Congress Programme Committee. "Entitled 'Prevention of Cardiovascular Disease from cell to man to society', our highlight offers the opportunity for doctors, scientists and governments to come together to discuss ways of decreasing the burden of cardiovascular disease on society."

New joint sessions with sister societies, such as the European Society of Medical Oncology, looking at issues such as the cardiovascular effects of oncology drugs, and a new joint session with the European Commission that will explore the issues around how the European Commission supports cardiovascular research are on the programme this year.

The ESC Congress is a unique forum bringing together all the different disciplines and players involved in cardiology, including doctors, basic scientists, epidemiologists, nurses, technicians and key opinion leaders. It covers both specific issues in the different disciplines as well as broader issues affecting all fields of cardiology.
The European Society of Cardiology (ESC) represents 59,000 cardiology professionals across Europe and the Mediterranean. Its mission is to reduce the burden of cardiovascular disease in Europe.

Registration for press is free. Journalists can register online before 31 July 2009. If you have not registered by 01 August 2009, you will need to register on-site in Barcelona.

European Society of Cardiology

Related Cardiovascular Disease Articles from Brightsurf:

Changes by income level in cardiovascular disease in US
Researchers examined changes in how common cardiovascular disease was in the highest-income earners compared with the rest of the population in the United States between 1999 and 2016.

Fighting cardiovascular disease with acne drug
Researchers from the European Molecular Biology Laboratory (EMBL) in Heidelberg and Stanford University have found the cause of dilated cardiomyopathy - a leading cause of heart failure - and identified a potential treatment for it: a drug already used to treat acne.

A talk with your GP may prevent cardiovascular disease
Having a general practitioner (GP) who is trained in motivational interviewing may reduce your risk of getting cardiovascular disease.

Dilemma of COVID-19, aging and cardiovascular disease
Whether individuals should continue to take angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the context of coronavirus disease 2019 (COVID-19) is discussed in this article.

Air pollution linked to dementia and cardiovascular disease
People continuously exposed to air pollution are at increased risk of dementia, especially if they also suffer from cardiovascular diseases, according to a study at Karolinska Institutet in Sweden published in the journal JAMA Neurology.

New insights into the effect of aging on cardiovascular disease
Aging adults are more likely to have - and die from - cardiovascular disease than their younger counterparts.

Premature death from cardiovascular disease
National data were used to examine changes from 2000 to 2015 in premature death (ages 25 to 64) from cardiovascular disease in the United States.

Ultrasound: The potential power for cardiovascular disease therapy
In the current issue of Cardiovascular Innovations and Applications volume 4, issue 2, pp.

Despite the ACA, millions of Americans with cardiovascular disease still can't get care
Cardiovascular disease (CVD) is the leading cause of death for Americans, yet millions with CVD or cardiovascular risk factors (CVRF) still can't access the care they need, even years after the implementation of the Affordable Care Act (ACA).

Excess weight and body fat cause cardiovascular disease
In the first Mendelian randomization study to look at this, researchers have found evidence that excess weight and body fat cause a range of heart and blood vessel diseases (rather than just being associated with it).

Read More: Cardiovascular Disease News and Cardiovascular Disease Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to